Epix Partners With GlaxoSmithKline

Epix Pharmaceuticals Inc. (EPIX) entered a partnership with GlaxoSmithKline plc (GSK) to jointly develop drugs. Shares of Epix soared $1.67 to close at $7.19 while GlaxoSmithKline stock edged up 57 cents to close at $53.00.